Musculoskeletal Diseases clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization
open to eligible people ages 40-79
An open label, prospective, two-arm, multicenter, randomized controlled trial comparing SakuraBead genicular artery embolization (GAE) with a control (corticosteroid injection).
at UCLA
Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients
Sorry, in progress, not accepting new patients
AOC 1001-CS2 (MARINA-OLE) is a Phase 2 extension of the AOC 1001-CS1 (MARINA) study to evaluate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of multiple-doses of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) patients
at UCLA
Our lead scientists for Musculoskeletal Diseases research studies include Susie Park, MD.
Last updated: